Provided by Tiger Trade Technology Pte. Ltd.

ASCENTAGE

30.740
+0.3801.25%
Volume:2.83M
Turnover:86.25M
Market Cap:11.50B
PE:-8.81
High:31.040
Open:30.000
Low:29.740
Close:30.360
52wk High:79.300
52wk Low:28.200
Shares:374.00M
HK Float Shares:374.00M
Volume Ratio:1.13
T/O Rate:0.76%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-3.490
ROE:-236.63%
ROA:-28.04%
PB:17.68
PE(LYR):-8.81
PS:15.31

Loading ...

ASCENTAGE-B: Trustee Acquires 50,000 Shares for 2022 RSU Scheme at HK$38.20 Each

Bulletin Express
·
May 28

ASCENTAGE PHARMA GROUP-B Executes Share Purchase for Incentive Plan

Stock News
·
May 28

Ascentage Pharma trustee buys 50,000 shares for 2022 RSU scheme, pays HK$1.91 million

Reuters
·
May 28

Movement Alert|Ascentage Pharma Falls 6.24% in Regular Trading, Biotech Sector Broadly Under Pressure

Market Focus
·
May 28

ASCENTAGE PHARMA GROUP-B Purchases 100,000 Shares Under 2022 Restricted Stock Unit Plan

Stock News
·
May 27

ASCENTAGE-B to Drop "B" Designation from Company Name in 2026

Stock News
·
May 27

Ascentage Pharma held shareholder vote approving director elections, mandates, and share awards

Reuters
·
May 22

Ascentage Pharma posts ASCO data on olverembatinib plus blinatumomab in Ph+ leukemia

Reuters
·
May 22

Ascentage Pharma Releases Latest Clinical Data From Multiple Trials at Asco 2026

THOMSON REUTERS
·
May 22

ASCENTAGE PHARMA GROUP to Unveil Multiple Clinical Advancements at 2026 ASCO Annual Meeting

Stock News
·
May 22

Ascentage Pharma showcases six clinical updates at ASCO 2026, highlighting olverembatinib, lisaftoclax and alrizomadlin progress

Bulletin Express
·
May 22

ASCENTAGE-B Adopts Third Amended & Restated Memorandum and Articles, Streamlining Governance and Shareholder Rights

Bulletin Express
·
May 21

Movement Alert|Ascentage Pharma Rises 7.32% in Regular Trading, Shareholder Meeting Signals Self-Commercialization Strategy Plus Guideline Inclusion

Market Focus
·
May 21

Ascentage Pharma presents updated Phase 3 POLARIS-1 olverembatinib data at EHA2026

Reuters
·
May 13

Ascentage Pharma management attends three investor conferences, including Stifel forum fireside chat

Reuters
·
May 12

ASCENTAGE-B Issues 10,058 New Shares in April; Public Float Remains Compliant

Bulletin Express
·
May 07

ASCENTAGE-B issues supplemental AGM notice; shareholders to vote on new RSU and option grants for Dr. Yang and Dr. Zhai

Bulletin Express
·
Apr 30

Ascentage Pharma announces shareholder meeting notice

Reuters
·
Apr 30

Ascentage Pharma FY25 net loss widens 206.4% to RMB 1.24 billion

Reuters
·
Apr 30

Ascentage Pharma announces annual general meeting

Reuters
·
Apr 29